Post Covid-19 Quality of Life After Hospital Discharge in Patients Treated With NIV/C-PAP

Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria145 enrolled

Overview

A multicenter longitudinal study with data collection at 4 and 8 months after hospital discharge.

The study population consisted of patients treated with NIV/CPAP, admitted to the COVID-19 wards of the AO SS Antonio e Biagio and Cesare Arrigo in Alessandria (the promoting center), the Azienda Sanitaria Locale Bt (Barletta, Andria, Trani) and the Azienda Socio Sanitaria Territoriale in Lecco, from November 2020 to June 2021. The study assessed at 4 and 8 months after hospital discharge in the patient's home environment, quality of life, residual disability, anxiety and insomnia. Enrollment took place only after the approval of the Ethics Committee of each participating center.

Study Type

OBSERVATIONAL

Enrollment

145

Conditions

Quality of Life

Interventions

administration of questionnairesBEHAVIORAL

administration of questionnaires

Eligibility

Sex: ALLMin age: 18 YearsMax age: 95 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: All patients aged ≥18 years admitted for COVID-19 pneumonia treated with NIV/CPAP, discharged to their home with a negative molecular swab and signed informed consent were included in the study Exclusion Criteria: Exclusion criteria were set in; patients admitted for COVID-19 pneumonia treated with NIV/CPAP and invasive ventilation and patients with pre-existing cognitive disorders at the hospital admission date.

Locations (1)

Azienda ospedaliera nazionale SS Antonio e Biagio e Cesare Arrigo

Alessandria, Italy

Outcomes

Primary Outcomes

COVID-19 qualità di vita

polmonite COVID-19 qualità di vita

Time frame: 8 mesi

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.